Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) rose 3.7% during mid-day trading on Tuesday . The company traded as high as $51.07 and last traded at $51.05. Approximately 18,004 shares changed hands during trading, a decline of 65% from the average daily volume of 51,430 shares. The stock had previously closed at $49.24.
SPDR S&P Pharmaceuticals ETF Stock Performance
The company has a 50 day moving average price of $48.01 and a 200 day moving average price of $44.26. The company has a market capitalization of $188.89 million, a price-to-earnings ratio of 14.28 and a beta of 0.60.
Institutional Investors Weigh In On SPDR S&P Pharmaceuticals ETF
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Simplex Trading LLC bought a new stake in SPDR S&P Pharmaceuticals ETF during the first quarter worth $27,000. Blair William & Co. IL bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 1st quarter worth $30,000. Advantage Trust Co increased its holdings in SPDR S&P Pharmaceuticals ETF by 1,525.0% in the 2nd quarter. Advantage Trust Co now owns 3,250 shares of the company’s stock worth $132,000 after acquiring an additional 3,050 shares during the last quarter. Rockport Wealth LLC bought a new stake in SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at about $203,000. Finally, Sigma Planning Corp lifted its holdings in SPDR S&P Pharmaceuticals ETF by 14.5% during the first quarter. Sigma Planning Corp now owns 5,894 shares of the company’s stock valued at $258,000 after purchasing an additional 747 shares during the last quarter.
SPDR S&P Pharmaceuticals ETF Company Profile
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- What Is WallStreetBets and What Stocks Are They Targeting?
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Should You Invest in Penny Stocks?
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
